title: Assessing the costs of second-generation antipsychotics.
authors.forename: Paul N
authors.initials: PN
authors.lastname: Pfeiffer
authors.forename: Marcia
authors.initials: M
authors.lastname: Valenstein
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics*; D002318:Cardiovascular Diseases / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D016903:Drug Monitoring / Q000191:economics*; D006801:Humans
chemical_list: D014150:Antipsychotic Agents